Cargando…

Racial differences in the distribution of bladder cancer metastases: a population-based analysis

INTRODUCTION: Bladder cancer is the second most common genitourinary malignancy in the United States. The incidence of bladder cancer rises with age, and it is two times more common in Caucasians than in African-Americans (23.1 vs. 12.6 cases/100,000 persons). We aimed to investigate the racial and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosiello, Giuseppe, Palumbo, Carlotta, Deuker, Marina, Stolzenbach, Lara Franziska, Martin, Thomas, Tian, Zhe, Gallina, Andrea, Montorsi, Francesco, Black, Peter, Kassouf, Wassim, Shariat, Shahrokh F., Saad, Fred, Briganti, Alberto, Karakiewicz, Pierre I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848828/ https://www.ncbi.nlm.nih.gov/pubmed/33552564 http://dx.doi.org/10.5173/ceju.2020.0269

Ejemplares similares

PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions
por: Deuker, Marina, et al.
Publicado: (2020)

Bladder cancer stage and mortality: urban vs. rural residency
por: Deuker, Marina, et al.
Publicado: (2020)

Primary lymphomas of the genitourinary tract: A population-based study
por: Palumbo, Carlotta, et al.
Publicado: (2020)

Differences between rural and urban prostate cancer patients
por: Stolzenbach, Lara Franziska, et al.
Publicado: (2020)

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations
por: Nocera, Luigi, et al.
Publicado: (2022)

Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
por: Moschini, Marco, et al.
Publicado: (2018)

Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy
por: Chierigo, Francesco, et al.
Publicado: (2022)

Plasmacytoid urothelial carcinoma of the bladder: a case report
por: Aldousari, Saad, et al.
Publicado: (2009)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2020)

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021)

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)

The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2023)

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
por: Tholomier, Côme, et al.
Publicado: (2020)

Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients
por: Tappero, Stefano, et al.
Publicado: (2022)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2022)

The association of the type and number of D’Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2023)

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
por: Monteiro, Leonardo L., et al.
Publicado: (2017)

Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature
por: Mbeutcha, Aurélie, et al.
Publicado: (2016)

Contemporary seminal vesicle invasion rates in NCCN high‐risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Collà Ruvolo , Claudia, et al.
Publicado: (2021)

Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

The impact of moderate wine consumption on the risk of developing prostate cancer
por: Vartolomei, Mihai Dorin, et al.
Publicado: (2018)

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2022)

Penile rehabilitation after radical prostatectomy: does it work?
por: Gandaglia, Giorgio, et al.
Publicado: (2015)

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes
por: Moschini, Marco, et al.
Publicado: (2019)

A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013)

Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer
por: Mansure, Jose Joao, et al.
Publicado: (2013)

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2021)

Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data
por: Moschini, Marco, et al.
Publicado: (2018)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v1nurqqsrnufk2rp1bkg0mqbkp